Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/4jwe-nx43

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Persistent and stable growth promoting effects of vosoritide in children with achondorplasia for up to 2 years: Results from the ongoing Phase 3 extension study

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Effects of Setmelanotide in Patients with POMC, PCSK1, or LEPR Heterozygous Deficiency Obesity in a Phase 2 Study
technical paper

Effects of Setmelanotide in Patients with POMC, PCSK1, or LEPR Heterozygous Deficiency Obesity in a Phase 2 Study

ENDO 2021

21 March 2021

Similar lecture

Ovarian Morphology From Childhood into AdulthoodRelevance to the Diagnosis of Polycystic Ovary Syndrome
technical paper

Ovarian Morphology From Childhood into AdulthoodRelevance to the Diagnosis of Polycystic Ovary Syndrome

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved